In the DC group, anti-FHL1+ autoantibodies were present in SS (2/100, 2%), RA (1/100, 1%), SLE (5/10, 50%), and SSc (5/10, 50%) (Fig. 1B). This evidence concerns the gene FHL1 and rheumatoid arthritis.